However, the result demonstrated that pancreatic cancer patients with high SPHK1 expression were significantly related to the location of tumor in the pancreas (P = 0.007), clinical stage (P = 0.013), and tumor status (stage T, P = 0.03). Here, SPHK1 is linked to familial pancreatic carcinoma.